.jpg)
.jpg)
Tulane Medical School
Dr. Pedro Barata earned his medical degree from the New University of Lisbon in 2009 and completed his medical oncology fellowship in 2016. During his training, he spent one year in the USA rotating at the Phase I Department at M.D. Anderson Cancer Center, Houston, and
at Taussig Cancer Center, Cleveland Clinic, Cleveland.
After completion of his fellowship, he was invited to join the genitourinary group at Taussig Cancer Center, where he worked as a clinical experimental therapeutics fellow in clinical research with focus on genitourinary cancers.
Subsequently, Dr Barata moved to Tulane University, where he continues his clinical and research work in the GU field and works to expand the program offered at Tulane Medical School. Dr Barata's interests includes immnotherapy, genomics and clinical trials and he currently leads the non-prostate GU program offered at Tulane University.
As a result of his clinical and research work, Dr. Barata authored and co-authored dozens of research publications in high-quality journals. Additionally, he has presented dozens of research abstracts at important national and international meetings and has authored textbook chapters and clinical reviews. Additionally, he serves as a reviewer for prestigious peer-reviewed journals and currently serves as the Associate Editor for The Oncologist journal and is the Assistant Editor for Clinical Genitourinary Cancer journal and Member of the Editorial Board of the Translational Oncology journal.
Disclosure information not submitted.
Saturday, May 14, 2022
2:30 PM – 3:30 PM
Sunday, May 15, 2022
12:10 PM – 12:20 PM
Sunday, May 15, 2022
12:30 PM – 1:00 PM